Cargando…

Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020

BACKGROUND: Lung cancer is the third most frequent tumor and the main cause of death by tumor in Spain. Although the incidence and mortality are still significantly higher in men than in women, the disparity between the sexes is decreasing. The objective of this study was to analyze the evolution of...

Descripción completa

Detalles Bibliográficos
Autores principales: Galindo-Utrero, Abraham, San-Román-Montero, Jesús María, Gil-Prieto, Ruth, Gil-de-Miguel, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680125/
https://www.ncbi.nlm.nih.gov/pubmed/36411427
http://dx.doi.org/10.1186/s12885-022-10205-2
_version_ 1784834341723963392
author Galindo-Utrero, Abraham
San-Román-Montero, Jesús María
Gil-Prieto, Ruth
Gil-de-Miguel, Ángel
author_facet Galindo-Utrero, Abraham
San-Román-Montero, Jesús María
Gil-Prieto, Ruth
Gil-de-Miguel, Ángel
author_sort Galindo-Utrero, Abraham
collection PubMed
description BACKGROUND: Lung cancer is the third most frequent tumor and the main cause of death by tumor in Spain. Although the incidence and mortality are still significantly higher in men than in women, the disparity between the sexes is decreasing. The objective of this study was to analyze the evolution of lung cancer hospitalization and in-hospital mortality rates in Spain from 2010 to 2020. METHODS: The reports of the Minimum Basic Data Set (MBDS) at hospital discharge were used to retrospectively analyze the data of all patients with a primary diagnosis of lung cancer, according to the International Classification of Diseases (ICD-9-CM and ICD-10-CM). RESULTS: Between 2010 and 2020, there were 315,263 hospitalizations and 70,490 deaths from lung cancer in Spain, the majority (~ 80%) in men. Overall, the rates of hospitalization and in-hospital mortality from lung cancer showed a downward trend throughout the period, although the number of new diagnoses and the absolute number of deaths in women increased. Due to the aging of the population, the degree of comorbidity in patients with lung cancer, although it remains relatively low, is also on the rise. CONCLUSION: Lung cancer represents a substantial clinical and economic burden for patients and for the National Health System, so it is necessary to promote primary prevention campaigns, as well as to develop more effective population screening measures to detect cancers early and increase the patient survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10205-2.
format Online
Article
Text
id pubmed-9680125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96801252022-11-23 Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020 Galindo-Utrero, Abraham San-Román-Montero, Jesús María Gil-Prieto, Ruth Gil-de-Miguel, Ángel BMC Cancer Research BACKGROUND: Lung cancer is the third most frequent tumor and the main cause of death by tumor in Spain. Although the incidence and mortality are still significantly higher in men than in women, the disparity between the sexes is decreasing. The objective of this study was to analyze the evolution of lung cancer hospitalization and in-hospital mortality rates in Spain from 2010 to 2020. METHODS: The reports of the Minimum Basic Data Set (MBDS) at hospital discharge were used to retrospectively analyze the data of all patients with a primary diagnosis of lung cancer, according to the International Classification of Diseases (ICD-9-CM and ICD-10-CM). RESULTS: Between 2010 and 2020, there were 315,263 hospitalizations and 70,490 deaths from lung cancer in Spain, the majority (~ 80%) in men. Overall, the rates of hospitalization and in-hospital mortality from lung cancer showed a downward trend throughout the period, although the number of new diagnoses and the absolute number of deaths in women increased. Due to the aging of the population, the degree of comorbidity in patients with lung cancer, although it remains relatively low, is also on the rise. CONCLUSION: Lung cancer represents a substantial clinical and economic burden for patients and for the National Health System, so it is necessary to promote primary prevention campaigns, as well as to develop more effective population screening measures to detect cancers early and increase the patient survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10205-2. BioMed Central 2022-11-21 /pmc/articles/PMC9680125/ /pubmed/36411427 http://dx.doi.org/10.1186/s12885-022-10205-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Galindo-Utrero, Abraham
San-Román-Montero, Jesús María
Gil-Prieto, Ruth
Gil-de-Miguel, Ángel
Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title_full Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title_fullStr Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title_full_unstemmed Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title_short Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
title_sort trends in hospitalization and in-hospital mortality rates among patients with lung cancer in spain between 2010 and 2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680125/
https://www.ncbi.nlm.nih.gov/pubmed/36411427
http://dx.doi.org/10.1186/s12885-022-10205-2
work_keys_str_mv AT galindoutreroabraham trendsinhospitalizationandinhospitalmortalityratesamongpatientswithlungcancerinspainbetween2010and2020
AT sanromanmonterojesusmaria trendsinhospitalizationandinhospitalmortalityratesamongpatientswithlungcancerinspainbetween2010and2020
AT gilprietoruth trendsinhospitalizationandinhospitalmortalityratesamongpatientswithlungcancerinspainbetween2010and2020
AT gildemiguelangel trendsinhospitalizationandinhospitalmortalityratesamongpatientswithlungcancerinspainbetween2010and2020